advertisement

Oculus

11.5.1 Systemic (45)

Showing records 1 to 25

Display only abstracts from IGR 21-2 in classification 11.5.1 Systemic

Search within classification 11.5.1 Systemic

90013 Intraocular and intracranial pressure in glaucoma patients taking acetazolamide
Loiselle AR; de Kleine E; van Dijk P; Jansonius NM
PLoS ONE 2020; 15: e0234690 (IGR: 21-3)


86436 An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
Supuran CT
Expert Opinion on Drug Metabolism and Toxicology 2020; 16: 297-307 (IGR: 21-2)


86801 Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence
Schmickl CN; Owens RL; Orr JE; Edwards BA; Malhotra A
BMJ open respiratory research 2020; 7: (IGR: 21-2)


85133 Acetazolamide Intoxication in an Elderly Patient with Diabetes and Chronic Renal Failure after Cataract Surgery
Kerber JM; de Mello JD; Moura KBA; da Silva GC; Wawrzeniak IC; Rech TH
Case reports in critical care 2020; 2020: 3764972 (IGR: 21-1)


82147 Factors Impacting Outcomes and the Time to Recovery From Malignant Glaucoma
Thompson AC; Vu DM; Postel EA; Challa P
American Journal of Ophthalmology 2020; 209: 141-150 (IGR: 20-4)


80028 The Effect of Acetazolamide and Weight Loss on Intraocular Pressure in Idiopathic Intracranial Hypertension Patients
Banik R; Kupersmith MJ; Wang JK; Garvin MK;
Journal of Glaucoma 2019; 28: 352-356 (IGR: 20-2)


76879 Evaluating off-label uses of acetazolamide
Van Berkel MA; Elefritz JL
American Journal of Health-System Pharmacy 2018; 75: 524-531 (IGR: 19-3)


75493 Case report on choroidal effusion after oral acetazolamide administration: an unusual manifestation of a well-known idiosyncratic effect?
Hári-Kovács A; Soós J; Gyetvai T; Facskó A; Végh M
Orvosi Hetilap 2017; 158: 1998-2002 (IGR: 19-2)


74795 Ultrasound biomicroscopy in acetazolamide-induced myopic shift with appositional angle closure
Grigera JD; Grigera ED
Arquivos Brasileiros de Oftalmologia 2017; 80: 327-329 (IGR: 19-1)


71325 Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma
Hayashi K; Yoshida M; Manabe SI; Yoshimura K
Ophthalmology 2017; 124: 701-708 (IGR: 18-3)


67461 Possible association between acetazolamide administration during pregnancy and multiple congenital malformations
Al-Saleem AI; Al-Jobair AM
Drug design, development and therapy 2016; 10: 1471-1476 (IGR: 17-4)


60412 Change in Intraocular Pressure in the Fellow Eye After Glaucoma Surgery in 1 Eye
Kaushik S; Agarwal A; Kaur S; Lomi N; Raj S; Pandav SS
Journal of Glaucoma 2016; 25: 324-329 (IGR: 16-4)


58864 Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients
Murray CD; Wood D; Allgar V; Walters G; Gale RP
Eye 2014; 28: 1218-1222 (IGR: 16-3)


59398 Acetazolamide-related Life-threatening Hypophosphatemia in a Glaucoma Patient
Hu CY; Lee BJ; Cheng HF; Wang CY
Journal of Glaucoma 2015; 24: e31-e33 (IGR: 16-3)


53104 Antiglaucoma carbonic anhydrase inhibitors: a patent review
Masini E; Carta F; Scozzafava A; Supuran CT
Expert Opinion on Therapeutic Patents 2013; 23: 705-716 (IGR: 15-1)


53074 Argon laser peripheral iridoplasty versus systemic intraocular pressure-lowering medications as immediate management for acute phacomorphic angle closure
Lee JW; Lai JS; Yick DW; Yuen CY
Clinical Ophthalmology 2013; 7: 63-69 (IGR: 15-1)


52068 Acetazolamide-induced cilio-choroidal effusion after cataract surgery: unusual posterior involvement
Malagola R; Arrico L; Giannotti R; Pattavina L
Drug design, development and therapy 2013; 7: 33-36 (IGR: 14-4)


52088 Acute bilateral angle closure glaucoma induced by methazolamide
Aref AA; Sayyad FE; Ayres B; Lee RK
Clinical Ophthalmology 2013; 7: 279-282 (IGR: 14-4)


51952 Acetazolamide impairs fear memory consolidation in rodents
Yang MT; Chien WL; Lu DH; Liou HC; Fu WM
Neuropharmacology 2013; 67: 412-418 (IGR: 14-4)


50960 Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011)
Aggarwal M; McKenna R
Expert Opinion on Therapeutic Patents 2012; 22: 903-915 (IGR: 14-3)


50362 Short-Term Changes in Intraocular Pressure after Phacoemulsification in Glaucoma Patients
Fogagnolo P; Centofanti M; Figus M; Frezzotti P; Fea A; Ligorio P; Lembo A; Digiuni M; Lorenzi U; Rossetti L
Ophthalmologica 2012; 228: 154-158 (IGR: 14-2)


49017 Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy
Cheng JW; Cheng SW; Yu DY; Wei RL; Lu GC
Current Medical Research and Opinion 2012; 28: 543-550 (IGR: 14-1)


48973 Efficacy of Single Glaucoma Drug in Combined Timolol XE, Latanoprost and Brinzolamide Therapy: A Discontinuation Study
Kobayashi H
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 245-250 (IGR: 14-1)


49217 Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
Nakakura S; Tabuchi H; Baba Y; Maruiwa F; Ando N; Kanamoto T; Kiuchi Y
Clinical Ophthalmology 2012; 6: 369-375 (IGR: 14-1)


45874 Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension
Pfeiffer N
Graefe's Archive for Clinical and Experimental Ophthalmology 2011; 249: 1065-1071 (IGR: 13-2)



Issue 21-2

Change Issue


advertisement

WGC-2021